Vardis Supports 1Q Health: Axel Riedisser joins as CFO

Project

Vardis Supports 1Q Health: Axel Riedisser joins 1Q Health-Gruppe as Chief Financial Officer

The 1Q Health Group is a European CDMO (Contract Development and Manufacturing Organization)specializing in the development and contract manufacturing of pharmaceuticals and dietary supplements. It offers end-to-end services (“one-stop shop”) across the product lifecycle, including formulation development, production ,packaging, regulatory support, and logistics, with manufacturing sites in Germany and Austria.

Axel Riedisser has been appointed CFO, with a mandate to further accelerate the Buy-and-Build and post-merger integration strategy, strengthen and professionalize the finance function, and support the company on its path toward a successful exit.

He joins from private equity-backed Rausch International, where he served as Managing Director Finance. In this role, he played a key part in shaping the group’s financial direction and consolidating multiple acquisitions into a unified entity.

 

About Vardis

Vardis is a trusted partner for executive and board recruiting. Our partners personally conduct all candidate outreach, ensuring our clients are well-represented and get the top candidates to the table. To determine what drives exceptional returns, we’ve analyzed executive teams—pre-close and post-exit—across the 500 most successful PE investments, compiling over 1 million data points on leaders’ expertise, credentials and industry experience. This proprietary, data-driven approach helps us identify and secure executives with the traits that consistently deliver superior returns.

Share Your Comments: